
Top Tweets from J.P. Morgan 2017
Pharm Exec is back at the 2017 J.P. Morgan Healthcare Conference in San Francisco, CA.
Pharm Exec is back at the 2017 J.P. Morgan Healthcare Conference in San Francisco, CA. We will be updating this page frequently with the latest Twitter feedback during one of healthcare’s most exciting weeks. Stay tuned for the latest.
January 12th
"We do not worship at the shrine of orthodoxy. You know in order to make new things you must break old things."
- HealthIT Policy (@HITpol)January 12, 2017
John Driscoll gave a rousing talk to a packed room: "A shift to value is a shift to the home. This is MONSTER opportunity."
- Oxeon Partners (@OxeonPartners)January 12, 2017
CEO Adelene Perkins presenting at
- Infinity Pharma (@INFIPharma)January 12, 2017
Excited to be at Women in Bio panel post J.P. Morgan debrief
- Mace Cheng (@MeiHsinCheng)January 12, 2017
Final day
- Bonny P McClain (@graphemeconsult)January 12, 2017
Pfizer CFO D'Amelio loves the phrase 'rhythm of the business'. I dropped in on his
- Peter Loftus (@Loftus)January 12, 2017
Takeaway from
- Josh Berlin (@BioPharmaJosh)January 12, 2017
On final morning of
- Mike Huckman (@MikeHuckman)January 12, 2017
Paul Markovich, CEO of
- Vicert (@Vicert_Inc)January 12, 2017
January 11th
Key Quotes:
"More than 50% of our ideas come from offsite," proving a good idea can come from anywhere, says
- Ryan Flinn (@RS_Flinn)January 11, 2017
"With the growth in
- Mary Gallagher (@mgallagherUSA)January 11, 2017
Overheard in the
- Rebecca Robbins (@RebeccaDRobbins)January 11, 2017
"It depends" is answer to every industry question about China's medtech market - LEK's Helen Chen
- Josh Berlin (@BioPharmaJosh)January 11, 2017
Doctors didn't go to medical school to babysit patients. We need to empower consumers to take control of their health -
- Welltok (@Welltok)January 11, 2017
Mylan CEO Heather Bresch:
In interesting timing, Heather Bresch - controversial CEO of EpiPen maker - is taking questions at
- Dan Diamond (@ddiamond)January 11, 2017
- Tyler (@HCanalyst)January 11, 2017
Bresch: there is no such thing as pharma, biotech, generic anymore. The lines are blurred.
- Lisa LaMotta (@BioWriterChik)January 11, 2017
Bresch: drug pricing dynamics really need to be revisited - no mention of the EpiPen
- Sarah Pringle (@sarpring)January 11, 2017
A comment on pharma from our President-Elect:
Trump's drug-price comments heighten significance of imminent TV ad blitz planned by industry lobbying arm PhRMA to defend itself
- Peter Loftus (@Loftus)January 11, 2017
Transcript of Trump's pharma comments via NPR
- Matthew Herper (@matthewherper)January 11, 2017
- David Beard (@dabeard)January 11, 2017
Let's see if that changes the unbridled optimism at
- Marc Lichtenfeld (@stocksnboxing)January 11, 2017
Abbvie CEO Richard Gonzalez presents:
CEO Gonzalez at
- AbbVie (@abbvie)January 11, 2017
AbbVie breakout. No price increase ^1%? Maybe apt for "volume business" with long-term pipeline. Expect the unexpected.
- Wayne Koberstein (@WayneKoberstein)January 11, 2017
"No large innovation has come from within a system...You have to start thinking from scratch." –
- Lena Cheng, MD (@lena_cheng)January 11, 2017
.
- Varun Saxena (@VarunSaxena2)January 11, 2017
January 10th
Key Quotes from Day 2:
.
- Medidata (@Medidata)January 10, 2017
"Changes in the health system are confusing; worrisome," said Jane Axelrad
- EBD Group (@EBDgroup)January 10, 2017
"You can take a tea spoon of DNA and store every film and every book ever written" -- Juan Enriquez speaks at
- Greg Johnsen (@gregjohnsen)January 10, 2017
It is important that we stay focused on the sustainability of the
healthcare ecosystem for patients -Joaquin Duato
- JNJ Innovation (@JNJInnovation)January 10, 2017
"We've got it backwards and have been provider-centric for too long" David Feinberg, CEO of
- Jen Horonjeff (@jhoronjeff)January 10, 2017
Sessions for Day 2 are underway:
- a_silverstein (@a_silverstein)January 10, 2017
Every CEO at
- Tiffany Wilson (@TheTifWilson)January 10, 2017
- Madeleine (@ByMadeleineA)January 10, 2017
Holy moly. Power panel talking drug pricing at
- Brian Reid (@brianreid)January 10, 2017
Vice-President Joe Biden Pays a visit to speak about the Cancer Moonshot Initiative:
"That one thing you reach for is hope. Tell me..."
- Celine Takatsuno (@zceline)January 10, 2017
VP
- Jana Katsuyama (@JanaKTVU)January 10, 2017
Thank you
- Sandy (@CADcrush)January 10, 2017
.
- Rebecca Robbins (@RebeccaDRobbins)January 10, 2017
January 9th
JP Morgan CEO Jamie Dimon speaks at the luncheon:
I believe America is doing better than people think and therefore... Interest rates and currency could strengthen from here. -Dimon
- Paunie Samreth (@go_paunie)January 9, 2017
"Healthcare can be done a lot better. Drop the ideology." -
- Innovation UT System (@InnovationUTS)January 9, 2017
Highlights from Gilead CEO John F. Milligan, PhD's presentation:
- Bonny P McClain (@graphemeconsult)January 9, 2017
- Lisa LaMotta (@BioWriterChik)January 9, 2017
Milligan: NASH is a fairly big disease; 12M pts in the U.S. with the broader disease;
- BioWorld Today (@BioWorld)January 9, 2017
And just like that we're underway...
Our President & CEO
- Children's Hospital (@ChildrensPhila)January 9, 2017
Looking like a packed house for Day 1
Love the idea of hanging out at
- Balaji Gopalan (@BalajiGopalan73)January 9, 2017
- Matthew Herper (@matthewherper)January 9, 2017
Excitement Builds
Met big healthcare fund manager in
- Adam Feuerstein (@adamfeuerstein)January 9, 2017
- Arthur Klausner (@ArthurKlausner)January 9, 2017
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





